New anticonvulsants for use in pediatric patients (part I).
Kopec
K
K
Department of Pharmacy Practice, College of Pharmacy (M/C 886), University of Illinois at Chicago, 833 S Wood St., Room 164H, Chicago, IL 60612, USA.
D000085:Acetates / Q000494:pharmacology / Q000627:therapeutic use*; D000293:Adolescent; D000367:Age Factors; D000588:Amines; D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use*; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003509:Cyclohexanecarboxylic Acids; D004827:Epilepsy / Q000188:drug therapy*; D005632:Fructose / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D000077206:Gabapentin; D006801:Humans; D007223:Infant; D007555:Isoxazoles / Q000494:pharmacology / Q000627:therapeutic use*; D000078330:Oxcarbazepine; D000077236:Topiramate; D000078305:Zonisamide; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D007555:Isoxazoles; D000077236:Topiramate; D005632:Fructose; D002220:Carbamazepine; D000078305:Zonisamide; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D000078330:Oxcarbazepine